Bibliometric analysis of systemic lupus erythematosus during pregnancy from 2003 to 2024.

IF 2.9 Q3 IMMUNOLOGY Immunological Medicine Pub Date : 2025-12-01 Epub Date: 2025-03-28 DOI:10.1080/25785826.2025.2483811
Xinyan Zou, Xinfu Zou, Qiaoqiao Liu, Bingxin Zhou, Shujie He, Xiulan Liao, Hanqing Zhao
{"title":"Bibliometric analysis of systemic lupus erythematosus during pregnancy from 2003 to 2024.","authors":"Xinyan Zou, Xinfu Zou, Qiaoqiao Liu, Bingxin Zhou, Shujie He, Xiulan Liao, Hanqing Zhao","doi":"10.1080/25785826.2025.2483811","DOIUrl":null,"url":null,"abstract":"<p><p>Autoimmune diseases such as systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome have a significant impact on pregnancy, potentially exacerbating SLE symptoms and leading to miscarriage, pre-eclampsia and other pregnancy complications. To ensure the safety of SLE patients during pregnancy, experts have conducted in-depth research and provided recommendations. Therefore, it is necessary to provide a thorough summary of the current status, hotspots and emerging trends in this research field. We systematically searched the Web of Science Core Collection database for studies on SLE during pregnancy from 1 January 2003 to 24 March 2024. We then utilized CiteSpace to generate a knowledge visualization map. This analysis included a total of 2239 studies on SLE during pregnancy. The yearly volume of publications exhibits a persistent increasing trend. The United States had the highest number of publications and was the leading country, while the Czech Republic had the highest centrality and influence. The research focused on three main areas: (1) pregnancy outcomes in autoimmune diseases, (2) newborn-related diseases and complications and (3) medication management for patients with SLE during pregnancy. Our study offers both a visual and scientific synopsis of research concerning SLE during pregnancy, furnishing valuable insights and opening up new avenues for researchers.</p>","PeriodicalId":37286,"journal":{"name":"Immunological Medicine","volume":" ","pages":"318-334"},"PeriodicalIF":2.9000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunological Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/25785826.2025.2483811","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Autoimmune diseases such as systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome have a significant impact on pregnancy, potentially exacerbating SLE symptoms and leading to miscarriage, pre-eclampsia and other pregnancy complications. To ensure the safety of SLE patients during pregnancy, experts have conducted in-depth research and provided recommendations. Therefore, it is necessary to provide a thorough summary of the current status, hotspots and emerging trends in this research field. We systematically searched the Web of Science Core Collection database for studies on SLE during pregnancy from 1 January 2003 to 24 March 2024. We then utilized CiteSpace to generate a knowledge visualization map. This analysis included a total of 2239 studies on SLE during pregnancy. The yearly volume of publications exhibits a persistent increasing trend. The United States had the highest number of publications and was the leading country, while the Czech Republic had the highest centrality and influence. The research focused on three main areas: (1) pregnancy outcomes in autoimmune diseases, (2) newborn-related diseases and complications and (3) medication management for patients with SLE during pregnancy. Our study offers both a visual and scientific synopsis of research concerning SLE during pregnancy, furnishing valuable insights and opening up new avenues for researchers.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2003 ~ 2024年妊娠期系统性红斑狼疮文献计量学分析。
系统性红斑狼疮(SLE)和抗磷脂抗体综合征等自身免疫性疾病对妊娠有很大的影响,可能会加重系统性红斑狼疮的症状,导致流产、先兆子痫和其他妊娠并发症。为了确保系统性红斑狼疮患者在妊娠期间的安全,专家们进行了深入的研究并提出了建议。因此,有必要对这一研究领域的现状、热点和新趋势进行全面总结。我们在 Web of Science 核心数据库中系统地检索了 2003 年 1 月 1 日至 2024 年 3 月 24 日期间有关妊娠期系统性红斑狼疮的研究。然后,我们利用 CiteSpace 生成了知识可视化地图。这项分析共收录了 2239 项关于妊娠期系统性红斑狼疮的研究。每年的论文数量呈现出持续增长的趋势。美国的论文数量最多,是领先的国家,而捷克共和国则拥有最高的中心地位和影响力。研究主要集中在三个方面:(1)自身免疫性疾病的妊娠结局;(2)新生儿相关疾病和并发症;(3)系统性红斑狼疮患者在妊娠期间的用药管理。我们的研究提供了有关妊娠期系统性红斑狼疮研究的视觉和科学概要,为研究人员提供了宝贵的见解并开辟了新的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Immunological Medicine
Immunological Medicine Medicine-Immunology and Allergy
CiteScore
7.10
自引率
2.30%
发文量
19
审稿时长
19 weeks
期刊最新文献
Acute changes in indices of cardiac filling and function induced by high-dose intravenous methylprednisolone pulse therapy: a single-center prospective study. Correction. Neural regulation of gut inflammation via autonomic nerves: therapeutic implications for inflammatory bowel disease. Organ damage accrual in patients with newly onset systemic lupus erythematosus with neuropsychiatric symptoms and its clinical features in daily clinical practice: a single-center study. Identification of BHLHE40-expressing T cells in giant cell arteritis amplified by interleukin-1.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1